Company / PP&E (Net)
MEDICINOVA INC PP&E (Net) History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$8.3K
FY2025
5-year range
$8.3K / $57.6K
FY2021-FY2025
Trend
-67.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has fluctuated over the past 9 years, ranging from $8,340 in FY2025 to $82,414 in FY2013.
Based on SEC 10-K filings.
$8,340 in FY2025 with a 3-year CAGR of -43.1%.
Declined from $45,800 to $8,340 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -43.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -43.1%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 67.3% year-over-year.
- Peak pp&e (net) was recorded in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.3K | -67.3% |
| FY2024 | $25.5K | -44.3% |
| FY2023 | $45.8K | +1.2% |
| FY2022 | $45.3K | -21.4% |
| FY2021 | $57.6K | +28.4% |
| FY2014 | $44.8K | -45.6% |
| FY2013 | $82.4K | +5.0% |
| FY2012 | $78.5K | +166.7% |
| FY2011 | $29.4K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026